In The Cancer Genome Atlas (TCGA), a low expression of FOXO1 decreased the survival rate not only in lung adenocarcinoma, but also lung cancer (all), whereas a high expression of CGN decreased the survival rate in lung cancer (all) (Supplemental Figure S3). The gene discussed is FOXO1; the disease is lung adenocarcinoma.